Epidermal growth factor inhibits somatostatin-induced apoptosis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background. The somatostatin analogue octreotide impairs intestinal regeneration and the adaptive response to intestinal resection by inhibition of enterocyte migration and proliferation and increased apoptosis. Epidermal growth factor (EGF) stimulates regeneration and adaptation by increasing proliferation and reducing apoptosis. The aim of this study was to determine the effect of EGF on octreotide-induced enterocyte apoptosis. Methods. Twenty-four rabbits underwent patch enteroplasty in the distal ileum to stimulate the mucosa. There were four study groups: octreotide 250 μg/kg/day, EGF 40 μg/kg/day, EGF plus octreotide, and control. Normal ileal mucosa adjacent to the patch was evaluated at 7 days for villus height, crypt depth, crypt cell production rate (CCPR), and in situ end labeling of DNA fragmentation. Results. Octreotide alone increased apoptosis compared with controls at the villus tip (40 ± 7% vs 18 ± 7%, P < 0.05), lateral villus (9 ± 2% vs 3 ± 2%, P < 0.05), and crypt (15 ± 3% vs 10 ± 3%, P < 0.05). EGF decreased apoptosis in the crypt (2 ± 1%) and villus (6 ± 1% villus tip and 1 ± 1% lateral villus, P < 0.05) compartments. EGF inhibited octreotide- induced apoptosis in the crypt (5 ± 2%) but not the villus (31 ± 5% villus tip and 6 ± 2% lateral villus, P < 0.05). Mean DNA fragmentation was significantly greater in octreotide-treated animals (P < 0.05). The octreotide-treated animals had reduced crypt depth and villus height but normal CCPR compared with controls. EGF increased CCPR and crypt depth compared with controls. Combining EGF and octreotide resulted in crypt depth and CCPR similar to those of controls but reduced villus height. Conclusions. EGF inhibits octreotide-induced apoptosis. This effect is greater in crypt than in villus enterocytes. Octreotide appears to have both direct and indirect effects on enterocyte apoptosis.

Original languageEnglish (US)
Pages (from-to)95-100
Number of pages6
JournalJournal of Surgical Research
Volume81
Issue number1
DOIs
StatePublished - Jan 1999

Fingerprint

Octreotide
Somatostatin
Epidermal Growth Factor
Apoptosis
Enterocytes
DNA Fragmentation
Regeneration
Mucous Membrane
Ileum
Rabbits

Keywords

  • Apoptosis
  • Epidermal growth factor
  • Octreotide

ASJC Scopus subject areas

  • Surgery

Cite this

Epidermal growth factor inhibits somatostatin-induced apoptosis. / Thompson, Jon S.

In: Journal of Surgical Research, Vol. 81, No. 1, 01.1999, p. 95-100.

Research output: Contribution to journalArticle

@article{eab13fd91df4440cad542d4aa826ba82,
title = "Epidermal growth factor inhibits somatostatin-induced apoptosis",
abstract = "Background. The somatostatin analogue octreotide impairs intestinal regeneration and the adaptive response to intestinal resection by inhibition of enterocyte migration and proliferation and increased apoptosis. Epidermal growth factor (EGF) stimulates regeneration and adaptation by increasing proliferation and reducing apoptosis. The aim of this study was to determine the effect of EGF on octreotide-induced enterocyte apoptosis. Methods. Twenty-four rabbits underwent patch enteroplasty in the distal ileum to stimulate the mucosa. There were four study groups: octreotide 250 μg/kg/day, EGF 40 μg/kg/day, EGF plus octreotide, and control. Normal ileal mucosa adjacent to the patch was evaluated at 7 days for villus height, crypt depth, crypt cell production rate (CCPR), and in situ end labeling of DNA fragmentation. Results. Octreotide alone increased apoptosis compared with controls at the villus tip (40 ± 7{\%} vs 18 ± 7{\%}, P < 0.05), lateral villus (9 ± 2{\%} vs 3 ± 2{\%}, P < 0.05), and crypt (15 ± 3{\%} vs 10 ± 3{\%}, P < 0.05). EGF decreased apoptosis in the crypt (2 ± 1{\%}) and villus (6 ± 1{\%} villus tip and 1 ± 1{\%} lateral villus, P < 0.05) compartments. EGF inhibited octreotide- induced apoptosis in the crypt (5 ± 2{\%}) but not the villus (31 ± 5{\%} villus tip and 6 ± 2{\%} lateral villus, P < 0.05). Mean DNA fragmentation was significantly greater in octreotide-treated animals (P < 0.05). The octreotide-treated animals had reduced crypt depth and villus height but normal CCPR compared with controls. EGF increased CCPR and crypt depth compared with controls. Combining EGF and octreotide resulted in crypt depth and CCPR similar to those of controls but reduced villus height. Conclusions. EGF inhibits octreotide-induced apoptosis. This effect is greater in crypt than in villus enterocytes. Octreotide appears to have both direct and indirect effects on enterocyte apoptosis.",
keywords = "Apoptosis, Epidermal growth factor, Octreotide",
author = "Thompson, {Jon S}",
year = "1999",
month = "1",
doi = "10.1006/jsre.1998.5468",
language = "English (US)",
volume = "81",
pages = "95--100",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Epidermal growth factor inhibits somatostatin-induced apoptosis

AU - Thompson, Jon S

PY - 1999/1

Y1 - 1999/1

N2 - Background. The somatostatin analogue octreotide impairs intestinal regeneration and the adaptive response to intestinal resection by inhibition of enterocyte migration and proliferation and increased apoptosis. Epidermal growth factor (EGF) stimulates regeneration and adaptation by increasing proliferation and reducing apoptosis. The aim of this study was to determine the effect of EGF on octreotide-induced enterocyte apoptosis. Methods. Twenty-four rabbits underwent patch enteroplasty in the distal ileum to stimulate the mucosa. There were four study groups: octreotide 250 μg/kg/day, EGF 40 μg/kg/day, EGF plus octreotide, and control. Normal ileal mucosa adjacent to the patch was evaluated at 7 days for villus height, crypt depth, crypt cell production rate (CCPR), and in situ end labeling of DNA fragmentation. Results. Octreotide alone increased apoptosis compared with controls at the villus tip (40 ± 7% vs 18 ± 7%, P < 0.05), lateral villus (9 ± 2% vs 3 ± 2%, P < 0.05), and crypt (15 ± 3% vs 10 ± 3%, P < 0.05). EGF decreased apoptosis in the crypt (2 ± 1%) and villus (6 ± 1% villus tip and 1 ± 1% lateral villus, P < 0.05) compartments. EGF inhibited octreotide- induced apoptosis in the crypt (5 ± 2%) but not the villus (31 ± 5% villus tip and 6 ± 2% lateral villus, P < 0.05). Mean DNA fragmentation was significantly greater in octreotide-treated animals (P < 0.05). The octreotide-treated animals had reduced crypt depth and villus height but normal CCPR compared with controls. EGF increased CCPR and crypt depth compared with controls. Combining EGF and octreotide resulted in crypt depth and CCPR similar to those of controls but reduced villus height. Conclusions. EGF inhibits octreotide-induced apoptosis. This effect is greater in crypt than in villus enterocytes. Octreotide appears to have both direct and indirect effects on enterocyte apoptosis.

AB - Background. The somatostatin analogue octreotide impairs intestinal regeneration and the adaptive response to intestinal resection by inhibition of enterocyte migration and proliferation and increased apoptosis. Epidermal growth factor (EGF) stimulates regeneration and adaptation by increasing proliferation and reducing apoptosis. The aim of this study was to determine the effect of EGF on octreotide-induced enterocyte apoptosis. Methods. Twenty-four rabbits underwent patch enteroplasty in the distal ileum to stimulate the mucosa. There were four study groups: octreotide 250 μg/kg/day, EGF 40 μg/kg/day, EGF plus octreotide, and control. Normal ileal mucosa adjacent to the patch was evaluated at 7 days for villus height, crypt depth, crypt cell production rate (CCPR), and in situ end labeling of DNA fragmentation. Results. Octreotide alone increased apoptosis compared with controls at the villus tip (40 ± 7% vs 18 ± 7%, P < 0.05), lateral villus (9 ± 2% vs 3 ± 2%, P < 0.05), and crypt (15 ± 3% vs 10 ± 3%, P < 0.05). EGF decreased apoptosis in the crypt (2 ± 1%) and villus (6 ± 1% villus tip and 1 ± 1% lateral villus, P < 0.05) compartments. EGF inhibited octreotide- induced apoptosis in the crypt (5 ± 2%) but not the villus (31 ± 5% villus tip and 6 ± 2% lateral villus, P < 0.05). Mean DNA fragmentation was significantly greater in octreotide-treated animals (P < 0.05). The octreotide-treated animals had reduced crypt depth and villus height but normal CCPR compared with controls. EGF increased CCPR and crypt depth compared with controls. Combining EGF and octreotide resulted in crypt depth and CCPR similar to those of controls but reduced villus height. Conclusions. EGF inhibits octreotide-induced apoptosis. This effect is greater in crypt than in villus enterocytes. Octreotide appears to have both direct and indirect effects on enterocyte apoptosis.

KW - Apoptosis

KW - Epidermal growth factor

KW - Octreotide

UR - http://www.scopus.com/inward/record.url?scp=0032836448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032836448&partnerID=8YFLogxK

U2 - 10.1006/jsre.1998.5468

DO - 10.1006/jsre.1998.5468

M3 - Article

C2 - 9889066

AN - SCOPUS:0032836448

VL - 81

SP - 95

EP - 100

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -